GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Mapk9 | increases phosphorylation | EXP | | 6480464 | CTD | Lipopolysaccharides results in increased phosphorylation of MAPK9 protein | PMID:25557508 | Mapk9 | multiple interactions | EXP | | 6480464 | CTD | Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] | PMID:25557508 | Mapk9 | increases expression | ISO | Mapk9 (Mus musculus) | 6480464 | CTD | Lipopolysaccharides results in increased expression of MAPK9 mRNA; Lipopolysaccharides results in increased expression of MAPK9 protein; Lipopolysaccharides results in increased expression of MAPK9 protein modified form | PMID:15832817 PMID:35833596 PMID:37177863 | Mapk9 | increases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | CTD | Lipopolysaccharides results in increased phosphorylation of MAPK9 protein | PMID:21911040 PMID:22004089 PMID:24967690 PMID:27129696 | Mapk9 | increases phosphorylation | ISO | Mapk9 (Mus musculus) | 6480464 | CTD | Lipopolysaccharides results in increased phosphorylation of MAPK9 protein | PMID:14644621 PMID:16023107 PMID:20023007 PMID:20923188 PMID:21465277 PMID:22060784 PMID:22155741 PMID:25451575 PMID:25451593 PMID:25818598 PMID:27568862 PMID:28906110 PMID:29906494 PMID:32800949 PMID:35616142 PMID:35833596 | Mapk9 | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | CTD | 1,6-hexamethylene diisocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; [Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK9 protein; acetovanillone inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK9 protein]; acetovanillone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK9 protein]; CBR1 protein modified form inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; diphenyleneiodonium inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK9 protein]; DUSP1 mutant form inhibits the reaction [trichostatin A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]]; Eucalyptol inhibits the reaction [Lipopolysaccharides results in decreased expression of and results in decreased phosphorylation of MAPK9 protein]; eupafolin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; Fluorescein-5-isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; Lipopolysaccharides results in decreased expression of and results in decreased phosphorylation of MAPK9 protein; MAPK9 gene mutant form inhibits the reaction [Lipopolysaccharides promotes the reaction [TGFB1 results in increased expression of PDGFB mRNA]]; phthalic anhydride inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; trichostatin A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; trimellitic anhydride inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] | PMID:21391979 PMID:21911040 PMID:22004089 PMID:23872422 PMID:24967690 PMID:25818598 PMID:27129696 | Mapk9 | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | CTD | 2'-hydroxyflavanone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of MAPK9 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased phosphorylation of MAPK9 protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of MAPK9 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]]; [IL10 protein co-treated with Dexamethasone] inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK9 protein]; [Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAPK9 protein; [TLR4 protein co-treated with TNFRSF1A protein] affects the reaction [IL10 protein inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK9 protein]]; chromium mesoporphyrin inhibits the reaction [MAPK9 protein inhibits the reaction [Lipopolysaccharides results in decreased expression of TNF protein]]; coagulin-L inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK9 protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; ethyl N-allyl-N-(2-methyl-3-(4-(4-amidinophenoxycarbonyl)phenyl)propenoyl)aminoacetate methanesulfonate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; fucoxanthin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; GSTP1 protein inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; HMOX1 protein promotes the reaction [MAPK9 protein inhibits the reaction [Lipopolysaccharides results in decreased expression of TNF protein]]; IL10 protein inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK9 protein]; licochalcone B analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of MAPK9 mRNA]; Lipopolysaccharides promotes the reaction [Polystyrenes results in increased phosphorylation of MAPK9 protein]; MAPK9 protein inhibits the reaction [Lipopolysaccharides results in decreased expression of TNF protein]; Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; Plant Oils inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of MAPK9 mRNA]; Polystyrenes promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; prolinedithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; Rotenone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; soyasaponin Ab inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; tanshinone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; TLR4 protein affects the reaction [Lipopolysaccharides results in increased expression of MAPK9 protein]; TLR4 protein affects the reaction [TNFRSF1A protein affects the reaction [Lipopolysaccharides results in increased expression of MAPK9 protein]]; TNFRSF1A protein affects the reaction [Lipopolysaccharides results in increased expression of MAPK9 protein]; TNFRSF1A protein affects the reaction [TLR4 protein affects the reaction [Lipopolysaccharides results in increased expression of MAPK9 protein]]; wogonin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAPK9 protein] | PMID:14644621 PMID:16023107 PMID:19667931 PMID:20023007 PMID:21465277 PMID:22060784 PMID:23362215 PMID:23831309 PMID:25451593 PMID:27568862 PMID:28906110 PMID:29906494 PMID:32800949 PMID:35616142 PMID:35833596 PMID:37177863 | |
Go Back to source page | Continue to Ontology report |